18598935

Source:http://linkedlifedata.com/resource/pubmed/id/18598935

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C2347129
pubmed:issue	7
pubmed:dateCreated	2008-7-7
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100957246
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1474-5488
pubmed:author	pubmed-author:GelmonKarenK
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	698
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:18598935-Antibodies, Monoclonal, pubmed-meshheading:18598935-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18598935-Antineoplastic Agents, pubmed-meshheading:18598935-Breast Neoplasms, pubmed-meshheading:18598935-Female, pubmed-meshheading:18598935-History, 20th Century, pubmed-meshheading:18598935-Humans
pubmed:year	2008
pubmed:articleTitle	Part II: Milestones in personalised medicine--trastuzumab.
pubmed:affiliation	BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada. kgelmon@bccancer.bc.ca
pubmed:publicationType	Journal Article, Historical Article